Jim Simons Kura Oncology, Inc. Transaction History

Renaissance Technologies LLC

$63.4 Billion
Q4 2024

A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Kura Oncology, Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 597,810 shares of KURA stock, worth $4.96 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

597,810

Previous 106,110 463.39%

Holding current value

$4.96 Million

Previous $2.07 Million 151.13%

% of portfolio

0.01%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	BUY	$8.51 - $19.21 $4.18 Million - $9.45 Million	491,700 Added 463.39%	597,810 $5.21 Million
Q3 2024 Nov 13, 2024	SELL	$18.57 - $23.23 $280,221 - $350,540	-15,090 Reduced 12.45%	106,110 $2.07 Million
Q2 2024 Aug 09, 2024	SELL	$17.53 - $22.98 $2.09 Million - $2.73 Million	-119,000 Reduced 49.54%	121,200 $2.5 Million
Q1 2024 May 13, 2024	SELL	$13.42 - $23.53 $508,618 - $891,787	-37,900 Reduced 13.63%	240,200 $5.12 Million
Q4 2023 Feb 13, 2024	BUY	$7.58 - $14.38 $1.23 Million - $2.34 Million	162,500 Added 140.57%	278,100 $4 Million
Q3 2023 Nov 14, 2023	SELL	$8.44 - $11.86 $611,900 - $859,850	-72,500 Reduced 38.54%	115,600 $1.05 Million
Q2 2023 Aug 11, 2023	BUY	$9.62 - $13.99 $1.65 Million - $2.4 Million	171,500 Added 1033.13%	188,100 $1.99 Million
Q1 2023 May 12, 2023	BUY	$10.71 - $14.6 $177,786 - $242,360	16,600 New	16,600 $203,000
Q3 2022 Nov 14, 2022	SELL	$12.01 - $19.45 $246,205 - $398,725	-20,500 Reduced 14.14%	124,500 $1.7 Million
Q2 2022 Aug 12, 2022	SELL	$10.71 - $18.33 $1.43 Million - $2.45 Million	-133,400 Reduced 47.92%	145,000 $2.66 Million
Q1 2022 May 13, 2022	BUY	$11.78 - $16.98 $2.48 Million - $3.58 Million	210,700 Added 311.23%	278,400 $4.48 Million
Q4 2021 Feb 11, 2022	SELL	$12.22 - $19.57 $1.3 Million - $2.08 Million	-106,400 Reduced 61.11%	67,700 $948,000
Q3 2021 Nov 12, 2021	SELL	$15.42 - $21.72 $1.98 Million - $2.78 Million	-128,100 Reduced 42.39%	174,100 $3.26 Million
Q2 2021 Aug 13, 2021	BUY	$20.85 - $29.88 $6.3 Million - $9.03 Million	302,200 New	302,200 $6.3 Million
Q2 2020 Aug 13, 2020	SELL	$7.95 - $18.81 $677,904 - $1.6 Million	-85,271 Closed	0 $0
Q1 2020 May 14, 2020	BUY	$6.45 - $14.04 $549,997 - $1.2 Million	85,271 New	85,271 $848,000

Others Institutions Holding KURA

# of Institutions

193

Shares Held

77.5M

Call Options Held

103K

Put Options Held

106K

View Full List

About Kura Oncology, Inc.

Ticker KURA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,893,000
Market Cap $555M
Description
Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...

More about KURA

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Account